Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European shares start November on a two-year high

Published 11/01/2017, 06:37 AM
Updated 11/01/2017, 06:37 AM
© Reuters. The German share price index, DAX board, is seen at the stock exchange in Frankfurt

By Sujata Rao and Julien Ponthus

LONDON (Reuters) - European stocks surged to two-year peaks on Wednesday, lifted by resilient company earnings and record highs set in Asia and New York, though a 6 percent slump in Standard Chartered shares kept the banking sector under a cloud.

At 1000 GMT, the pan-European STOXX 600 (STOXX) rose 0.6 percent to 397.43 points, a level last seen in August 2015.

Some of that was down to Germany's DAX (GDAXI) index which, playing catch-up after Tuesday's holiday, jumped 1.3 percent to hit a fresh record high.

Markets continued to brush off concerns over Catalonia's independence bid, pushing Spain's IBEX (IBEX) up 0.5 percent.

The European benchmark is enjoying its fifth straight day of gains and rose almost 2 percent in October, having also taken a cue from global markets which have been propelled higher by hopes of U.S. tax cuts, economic recovery and a robust tech cycle.

"Economically everything looks good at the moment," said Jonathan Bell, chief investment officer at Stanhope Capital.

Bell cautioned, however, that while investors were riding the rising wave, markets could be vulnerable to monetary policy changes.

The day's top performer was British drugmaker Indivior (L:INDV) which soared 11.5 percent after U.S. authorities recommended approval for an opioid addiction drug. The stock has risen about 24 percent already this week.

"On our view (the recommendation) substantially increases the probability of approval ... which is material given its importance to future growth prospects," analysts at Jefferies told clients, rating the stock a Buy.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Fellow drugmaker, Denmark's Novo Nordisk (CO:NOVOb), lost 2.8 percent after publishing third-quarter results and warning that new legislation in some U.S. states could hurt business in its key market.

Still on the earnings front, forecast-beating third quarter results drove up shares in Finnish tyre maker Nokian Tyres by some 6 percent, while British bookmaker Paddy Power (I:PPB) jumped 4 percent to three-month highs.

Of the STOXX600 firms which have reported third quarter results, almost half have beaten forecasts, according to Thomson Reuters I/B/E/S, which also predicts average earnings to increase 3.5 percent over the same 2016 quarter.

But the latest earnings season has rekindled some worries for Europe's banking sector.

While BNP Paribas (PA:BNPP) shares extended the previous day's 2.7 percent fall due to disappointment in its fixed income trading operations, Standard Chartered (L:STAN) was Wednesday's biggest loser, with its biggest daily fall in three months.

While the Asia-focused lender posted a 78 percent rise in pre-tax profit, this was overshadowed by higher expenses and flat revenues, dashing investors' hopes for dividend payments.

Shares in Austria's Raiffeisen (VI:RBIV) bank also fell 2.1 percent.

Also bringing up the bottom of the index was British clothing retailer Next (L:NXT) which sank 6 percent after results fell short of analysts' expectations.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.